What INTERLAB GmbH does

INTERLAB GmbH is identified in the firmographic block as a Munich-based independent central laboratory founded in 1994, employing 101-250 people and supporting clinical trials for pharmaceutical and biotechnology companies. However, the source material aggregated for this analysis is in fact a detailed profile of SGS INSTITUT FRESENIUS GmbH, a German private limited company headquartered in Berlin that operates within the SGS Group — one of the world's leading inspection, verification, and testing conglomerates. Given the source-material conflict, the analytical description below is grounded in the documented SGS INSTITUT FRESENIUS profile. Under that profile, the company delivers contract laboratory and analytical services across five operating pillars: Health & Nutrition (pharmaceutical clinical trial laboratory testing across Phase I-IV, drug development analytics, food and feed testing, cosmetics and hygiene testing, and TraitGenetics genotyping); Industries & Environment (PFAS, asbestos, air/water/gas analysis, hygiene diagnostics); Consumer Goods & Retail (electrical devices, toys, textiles, furniture testing); and Materials & Failure Analysis (microelectronics, battery testing, plastics and composites). Its core technology stack consists of physical laboratory analysis, chemical and physical surface analytics, GLP-compliant study execution, extractables & leachables testing, and the SGS proderm European Center of Excellence for Dermatology Research.

Revenue is generated primarily through B2B contract laboratory services on a project-based, multi-year engagement model, with pricing negotiated per scope and complexity rather than published as tiers. Secondary revenue derives from the SGS Academy training platform, which delivers domain-specific training in pharmaceutical, food safety, and adjacent sectors in classroom and online formats. Distribution is sales-led: the company engages enterprise pharmaceutical and medical device clients directly through technical sales representatives, with the broader SGS Group network providing international reach and cross-sell into adjacent testing services. Customer segmentation is vertical (pharmaceutical/biopharma and medical devices as primary; food/feed, cosmetics, and industrial as secondary), and the company sells exclusively in Europe (primarily Germany).

The company has no public pricing, no disclosed revenue figures, and no public AI or API capabilities; differentiation rests on regulatory credentials (GLP), SGS Group affiliation, and specialized expertise in dermatology clinical research via SGS proderm.

Name

INTERLAB GmbH

Legal name

SGS INSTITUT FRESENIUS GmbH

Website

https://interlab.de

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

SGS INSTITUT FRESENIUS GmbH is a German contract laboratory services provider affiliated with the global SGS Group, delivering clinical trial laboratory testing, analytical laboratory services for drug development, GLP studies, and dermatology clinical research to pharmaceutical, medical device, food, and cosmetics clients across Europe.

Ownership category

akta.pro rank

Product category

Contract Laboratory Services

NAICS

Medical Laboratories (621511), Testing Laboratories and Services (54138), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

akta.pro secondary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Central laboratory services
• Clinical trial testing
• Pharmaceutical analytics
• Biopharmaceutical testing
• GLP-compliant studies

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Laboratory Testing Services: The company generates revenue primarily through providing contracted laboratory analysis and testing services to pharmaceutical, medical device, food, cosmetics, and chemical industry clients. Services are delivered across the drug development lifecycle from early-phase development through market launch. Revenue is project-based and recurring as clients return for additional testing needs across product lines and development stages.
2. Training Services (SGS Academy): Revenue generated from professional training programs offered through the SGS Academy, providing up-to-date training in pharmaceutical, food safety, and other industry domains in classroom and online formats.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

INTERLAB GmbH is an independent central laboratory that supports clinical trials for pharmaceutical and biotechnology companies. It provides analytical laboratory testing services, drug development support, and GLP-compliant study execution across clinical trial phases, primarily serving pharmaceutical and biopharmaceutical clients across all stages of drug development.

Product overview

SGS INSTITUT FRESENIUS offers a comprehensive portfolio of laboratory services for the pharmaceutical and life science industries. The company's service offerings include Clinical Trial Laboratory Testing for Phase I-IV studies, Clinical Research Services through partnership with SGS CRO, SGS proderm as the European Center of Excellence for Dermatology Research, and Analytical Laboratory Services and Drug Development. These services are complemented by SGS Academy training programs. The company leverages a global network of analytical contract laboratories with skilled scientific staff to support drug development from molecule to market launch.

Differentiator

Problem solved

Functional benefit

Brands

• SGS proderm: European Center of Excellence for Dermatology Research providing high-quality clinical studies and reliable contract research.
• SGS Analytics

Products and services

• Clinical Trial Laboratory Testing Central laboratory testing services supporting clinical trials across Phase I to Phase IV studies, including the various laboratory tests necessary for trial success.
• Analytical Laboratory Services and Drug Development Laboratory analysis of pharmaceutical products per desired requirements and regulations, test method development, and delivery of reliable, clearly documented test results for drug development.
• GLP-Compliant Studies Good Laboratory Practice (GLP) compliant studies for the chemical and pharmaceutical industries, supporting regulatory submissions and compliance requirements.
• Clinical Research Services (CRO) Clinical research services for Phase I to IV studies with focus on early development and biometrics, provided as part of a broader CRO offering for Health and Life Science.

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• SGS Group (Societe Generale de Surveillance)coreOthersSGS INSTITUT FRESENIUS operates as a subsidiary or brand within the broader SGS Group, one of the world's leading inspection, verification, and testing companies. The partnership provides access to SGS's global laboratory network, corporate resources, and cross-selling opportunities across the full portfolio of testing and certification services. The SGS Group connection enables international reach and credibility for the company.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and commercial services. Comparable on clinical research services and central lab support for Phase I–IV trials; broader commercial-services orientation differentiates it from a pure central lab operator.
• Eurofins Scientific: Eurofins is a leading global testing services group with deep pharma, food, cosmetics, and environmental testing capabilities across Europe, including central lab and clinical trial support. Comparable across multiple of the subject's verticals (pharma, food, cosmetics, environmental); broader portfolio and European headquarters make it a primary competitor.
• ICON plc: ICON is a top-5 global CRO providing clinical research and central laboratory services (formerly PRA Health) to pharma and biotech. Direct competitor for clinical trial central lab and Phase I–IV testing services; significantly larger scale and global lab footprint.
• Intertek Group: Intertek is a global quality assurance and testing company with pharma, food, and environmental testing services. Comparable across the subject's non-clinical testing lines (food, cosmetics, industrial materials); less central lab / clinical trial focus, but competes for the same regulated-industry QA/QC wallet.
• Charles River Laboratories: Charles River is a major CRO offering preclinical, clinical, and manufacturing services, with central lab capabilities supporting clinical trials. Directly comparable on clinical research and central lab services for pharma/biopharma sponsors, though skewed more toward preclinical and discovery than the subject's clinical-stage focus.
• IQVIA Holdings: IQVIA is the world's largest CRO and operates a global central laboratory network (Q² Solutions) supporting Phase I–IV clinical trials with bioanalytical, genomic, and biorepository services. Directly comparable on clinical trial central lab and clinical research services; competes for the same pharma/biopharma sponsors but at meaningfully larger scale.
• Bureau Veritas: Bureau Veritas is a global testing, inspection, and certification (TIC) company with commodity, industrial, and some life-sciences testing. Comparable on the industrial/material testing side; weaker overlap on the clinical central lab and pharma testing lines that are central to the subject's offering.
• Labcorp (and Fortrea spin-out): Labcorp historically operated one of the largest central lab networks supporting clinical trials globally, with Fortrea spun out to house the clinical development services business. Direct peer for clinical trial central lab services; comparable in service scope (central lab, bioanalytical, specialty testing) but substantially larger in scale and geographic reach.

Direct peers

• Frontage Laboratories: Frontage is a US-headquartered CRO providing bioanalytical, CMC, and central laboratory services to pharma/biotech sponsors. Closely comparable in service mix (central lab, bioanalytical, drug development support) and target customer (small-to-mid biopharma); similar mid-sized scale, making it a relevant direct peer for benchmarking.

Others

• SGS Group: SGS is the parent/affiliate organization of the subject entity and operates a global network of analytical and clinical laboratories. While not a direct competitor, SGS's broader testing portfolio (inspection, verification, certification) and global lab footprint are the mechanism through which the subject entity accesses international clients and cross-sell opportunities.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/SGS
• LinkedInlinkedin.com/company/interlab-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INTERLAB GmbH